Business Description
MetaVia Inc., formerly NeuroBo Pharmaceuticals, is a Cambridge, Massachusetts-based drug development company focused on treating heart and metabolic conditions such as liver disease, type 2 diabetes, and obesity. Its leading drug candidates, DA-1241 and DA-1726, are currently in clinical trials, while its broader pipeline also targets conditions including diabetic nerve pain, cognitive decline, and high cholesterol. The company holds a licensing agreement with Pfizer for one of its treatments and relies on its parent company, South Korean firm Dong-A ST, for manufacturing support.
